Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

ART Selection in Treatment-Naive PWH: Weight Gain Considerations

Source: Contemporary HIV Treatment and Prevention 2022
Listen to this patient case from Princy N. Kumar MD, FIDSA, MACP, as she shares the latest data on weight gain after ART initiation.
Princy N. Kumar, MD, FIDSA, MACP
Released: December 30, 2022

In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes a review of the following studies on ART and weight gain:

  • ADVANCE: men vs women receiving DTG + FTC/TAF, DTG + FTC/TDF, and EFV + FTC/TDF
  • Comparison of ART regimens (eg, INSTI-, NNRTI- and PI-based regimens) in a pooled analysis of 8 phase III randomized controlled trials
  • GEMINI-1 and GEMINI-2: DTG + 3TC vs DTG + FTC/TDF

Information on this Educational Activity

Faculty

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP, has no relevant financial relationships to disclose.

Program Medium

This program has been made available online.

Acknowledgements

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings